TNFRSF8 and neoplasm: The anti-tumor activity of clone 142-derived anti-CD30 CAR-T cells was further confirmed in vivo by a xenograft NSG mouse model of luciferase-positive HD-LM2 cells subcutaneous (s.c.)injection.